TriMas (TRS) Q3 2024 Earnings Call Transcript

The market is likely underestimating the quality of the mix shift here: Packaging and Aerospace are both moving from recovery to self-help, while Specialty is no longer the main drag on incremental margin. That matters because once the low-margin Specialty reset is mostly behind them, even modest top-line growth in the other two segments should translate into disproportionate EPS leverage over the next 2-4 quarters. The setup is less about this quarter’s headline miss and more about 2025 conversion upside as capacity additions and labor normalization catch up with demand.

The biggest second-order beneficiary is probably the supply chain around TriMas’s end markets, especially smaller peers that still lack the ability to absorb a demand snapback. In Packaging, the bottleneck relief should reduce lost sales and scrap/expedite costs, but it also raises the risk that competitors see pricing pressure if TriMas proves it can convert backlog faster without sacrificing margin. In Aerospace, a Europe-based foothold is strategically more important than the size of the deal suggests because it creates a direct channel into Airbus content and reduces the company’s dependence on U.S. labor execution.

The main risk is not the quarter; it is persistence. If the Boeing work stoppage or broader aerospace supply chain disruption extends into 2025, order timing can slip again and expose how much of the Aerospace rebound is still backlog-driven rather than true volume normalization. Specialty also remains a genuine cyclical call option on industrial and defense demand, but management is effectively saying the rebound may not show up until early 2025; if it does not, leverage cuts both ways because investors are paying for a cleaner, higher-quality mix that has not fully arrived yet.

Contrarianly, the stock may still be cheap if the market is valuing TriMas off depressed Specialty EBITDA and not giving enough credit to the operating leverage in Packaging. The more important debate is whether 2025 becomes an earnings upgrade year, not whether 2024 guidance is repeatable. If the guidance is maintained again next quarter despite a fully resolved labor issue, the multiple should begin to re-rate toward a higher-quality industrial compounder rather than a cyclical roll-up story.